posted
VANCOUVER, April 21 /PRNewswire-FirstCall/ - Robert Rieveley, President of Biotech Holdings (the "Company", TSX-V: BIO; OTC BB: BIOHF) announced today that the Company has received its first purchase order for its Sucanon diabetes drug from WAL-MART.
"I am pleased to report that we have received our first order from Wal-Mart Stores in Mexico for Sucanon. This Sucanon order, with delivery next week, is for Wal-Mart Superama stores," Mr. Rieveley said.
"Our Mexico office is also currently discussing orders for Sucanon with Wal-Mart's Supercenter stores division, its Warehouse stores division and its VIPS stores division. More information on these will be available shortly," Mr. Rieveley said.
If you would like to be added to Biotech Holdings' email list for future news updates or summary clinical materials, please click here: http://www.biotechltd.com/info.asp
Biotech Holdings Ltd.'s head office is in Richmond, British Columbia. Biotech Holdings' shares trade on the Over the Counter Bulletin Board in the United States (BIOHF.OB) and on the TSX Venture Exchange in Canada (BIO.V). For inquiries, contact Austin Rand, Biotech Holdings Ltd., 1-888-216-1111 (toll-free), 8:00 a.m. to 4 p.m. Pacific time, or by e-mail at biotech@direct.ca. For background information and current stock quotations, please visit Biotech's website at www.biotechltd.com.
-------------------- Greedy Because I'm Broke!! Posts: 2093 | From: Leaving Your House | Registered: Apr 2004
| IP: Logged |
UBBFriend: Email this page to someone!
Printer-friendly view of this topic
![[Big Grin]](biggrin.gif)
